{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:49:12Z","timestamp":1789058952600,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.molstruc.2021.131348","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T20:24:52Z","timestamp":1629577492000},"page":"131348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["[Cu(dipicolinoylamide)(NO3)(H2O)] as anti-COVID-19 and antibacterial drug candidate: Design, synthesis, crystal structure, DFT and molecular docking"],"prefix":"10.1016","volume":"1247","author":[{"given":"Laila H.","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram T.","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badriah Saad","family":"Al-Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaaban K.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Ramli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molstruc.2021.131348_bib0001","first-page":"655","article-title":"Clinical observation on the treatment of 63 suspected cases of novel coronavirus pneumonia with traditional Chinese medicine Lianhua Qingwen","volume":"61","author":"Lu","year":"2020","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.molstruc.2021.131348_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molstruc.2021.131348_bib0003","article-title":"Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis","volume":"80","author":"David Lee","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.molstruc.2021.131348_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajem.2020.12.014","article-title":"Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study","volume":"40","author":"O.Sogut","year":"2021","journal-title":"Am. J. Emergency Med."},{"key":"10.1016\/j.molstruc.2021.131348_bib0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molstruc.2021.131348_bib0006","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.molstruc.2021.131348_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2021.01.016","article-title":"Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies","volume":"86","author":"Pasin","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.molstruc.2021.131348_bib0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.molstruc.2021.131348_bib0009","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molstruc.2021.131348_bib0010","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19) A Review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.molstruc.2021.131348_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.molstruc.2021.131348_bib0012","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/microorganisms8050695","article-title":"Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE)","volume":"8","author":"Colaneri","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.molstruc.2021.131348_bib0013","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"129","author":"Quartuccio","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.molstruc.2021.131348_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.molstruc.2021.131348_bib0015","unstructured":"M. Parsey, An open letter from Merdad Parsey, Chief Medical Officer, Gilead Sciences, 2020. https:\/\/stories.gilead.com\/articles\/open-letter-from-merdad-par sey, (Accessed 22 October 2020)."},{"key":"10.1016\/j.molstruc.2021.131348_bib0016","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1021\/ja00433a061","article-title":"2,4,6-Tris(2-pyrimidyl)- and 2,4,6-tris(2-pyridyl)-1,3,5-triazines hydrolyze in the presence of copper(II) to form a novel bis(aryl)carboximidato chelate complex","volume":"98","author":"Lerner","year":"1976","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molstruc.2021.131348_bib0017","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/ic50172a060","article-title":"Heavy-metal complexes of 2,4,6-tris(2-pyrimidyl)-1,3,5-triazine. Structure of a dilead derivative","volume":"16","author":"Lerner","year":"1977","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.molstruc.2021.131348_bib0018","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1039\/a608433h","article-title":"Predominance of electron-withdrawing effect over angular strain in the metal-promoted hydrolysis of 2,4,6-tris(2-pyridyl)-1,3,5-triazine","author":"Paul","year":"1997","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.molstruc.2021.131348_bib0019","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1021\/ic9709739","article-title":"Synthesis and characterization of rhodium complexes containing 2,4,6-Tris(2-pyridyl)-1,3,5-triazine and its metal-promoted hydrolytic products: potential uses of the new complexes in electrocatalytic reduction of carbon dioxide","volume":"37","author":"Paul","year":"1998","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.molstruc.2021.131348_bib0020","series-title":"Program Name(S)","year":"2012"},{"key":"10.1016\/j.molstruc.2021.131348_bib0021","series-title":"Program Name","year":"2001"},{"key":"10.1016\/j.molstruc.2021.131348_bib0022","first-page":"3","article-title":"SHELXT - Integrated space-group and crystal-structure determination","volume":"A71","author":"Sheldrick","year":"2015","journal-title":"Acta Cryst."},{"key":"10.1016\/j.molstruc.2021.131348_bib0023","series-title":"SHELX: applications to macromolecules","first-page":"401","author":"Sheldrick","year":"1998"},{"key":"10.1016\/j.molstruc.2021.131348_bib0024","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"Report on a project on three-dimensional imaging of the biological cell by single-particle X-ray diffraction","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallographica Section A"},{"key":"10.1016\/j.molstruc.2021.131348_bib0025","series-title":"D.J. Fox, Gaussian 09","author":"Robb","year":"2009"},{"key":"10.1016\/j.molstruc.2021.131348_bib0026","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jccs.202000024","article-title":"Spectroscopic studies, Density Functional Theory calculations, and non-linear optical properties of binuclear Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) complexes of OONN Schiff base ligand","volume":"67","author":"Moustafa","year":"2020","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.molstruc.2021.131348_bib0027","unstructured":"Molecular Operating Environment (MOE), 2019. 01; Chemical Computing Group ULC, 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2019."},{"key":"10.1016\/j.molstruc.2021.131348_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molstruc.2021.131348_bib0029","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1074\/jbc.M007101200","article-title":"Inhibition of b-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin","volume":"276","author":"Price","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molstruc.2021.131348_bib0030","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.bbapap.2011.06.008","article-title":"Conformational basis for substrate recognition and regulation of catalytic activity in Staphylococcus aureus nucleoside di-phosphate kinase","volume":"1814","author":"Srivastava","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins Proteomics"},{"key":"10.1016\/j.molstruc.2021.131348_bib0031","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jsb.2016.07.008","article-title":"Crystal structure of a membrane-bound l-amino acid deaminase from Proteus vulgaris","volume":"195","author":"Ju","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.molstruc.2021.131348_bib0032","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1080\/00958970701209864","article-title":"Synthesis and characterization of some new mono- and binuclear copper(II) ternary complexes; X-ray crystal structure of copper(II)- N -(acetyl)phenylglycinateimidazole ternary complex","volume":"60","author":"Laila Abdel-Rahman","year":"2007","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.molstruc.2021.131348_bib0033","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/00958970600961664","article-title":"Complexes of zinc(II) and cadmium(II) with N-phthaloylglycinate, imidazole, 5-amino tetrazole and 2,4,6- tris (2-pyridyl)-1,3,5-triazine. X-ray crystal structure of [Cd(imi)3(N-phthgly)2]2H2O","volume":"60","author":"Laila Abdel-Rahman","year":"2007","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.molstruc.2021.131348_bib0034","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/00958970600556928","article-title":"Synthesis and spectroscopic properties of copper(II)-N- phthaloylglycinate derivatives of imidazole, methylimidazole, 1,10-phenanthroline and 2,2\u2032,2\u2033-terpyridine. Crystal structure of [Cu(OH2)2(phen)(N-phthgly)] (NO3)\u2009\u2009H2O and [Cu(terpy)(N-phthgly)2]\u00b7H2O","volume":"59","author":"Abdel-Rahman","year":"2006","journal-title":"J. Coord. Chem."}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021014770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021014770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:21:43Z","timestamp":1775233303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286021014770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"alternative-id":["S0022286021014770"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131348","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Cu(dipicolinoylamide)(NO3)(H2O)] as anti-COVID-19 and antibacterial drug candidate: Design, synthesis, crystal structure, DFT and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"131348"}}